Effects of oxygen-containing terpenes as skin permeation enhancers on the lipoidal pathways of human epidermal membrane

Journal of Pharmaceutical Sciences

Volumn 98, Issue 10, 2009, Pages 3617-3632

  Chantasart, Doungdaw ^a   Pongjanyakul, Thaned ^b   Higuchi, William I ^c   Li, S Kevin ^d  

^a MAHIDOL UNIVERSITY   (Thailand)

^b KHON KAEN UNIVERSITY   (Thailand)

^c UNIVERSITY OF UTAH   (United States)

^d UNIVERSITY OF CINCINNATI   (United States)

Author keywords

Human epidermal membrane; Lipoidal pathway; Oxygen containing terpenes; Permeant; Skin permeation enhancers

Indexed keywords

ALKANOL; ALKYLBENZENE; CINEOLE; CORTICOSTERONE; ESTRADIOL; MENTHOL; MENTHONE; OXYGEN; PENETRATION ENHANCING AGENT; TERPENE DERIVATIVE; THYMOL;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG STRUCTURE; EPIDERMIS; HUMAN; HUMAN CELL; STRATUM CORNEUM;

EID: 67649638118     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.21666     Document Type: Article

References (50)

1. Barry BW. 1991. Lipid-protein-partition theory of skin penetration enhancement. J Control Release 15:237-248.
2. Ogiso T, Iwaki M, Paku T. 1995. Effect of various enhancers on transdermal penetration of indomethacin and urea, and relationship between penetration parameters and enhancement factors. J Pharm Sci 84:482-488.
3. Sinha VR, Kaur MP. 2000. Permeation enhancers for transdermal drug delivery. Drug Dev Ind Pharm 26:1131-1140. (Pubitemid 30807498)
4. Williams AC, Barry BW. 1992. Skin absorption enhancers. Crit Rev Ther Drug Carr Sys 9:305-353.
5. Aqil M, Ahad A, Sultana Y, Ali A. 2007. Status of terpenes as skin penetration enhancers. Drug Discov Today 12:1061-1067. (Pubitemid 350180560)
6. Kanikkannan N, Kandimalla K, Lamba SS, Singh M. 2000. Structure-activity relationship of chemical penetration enhancers in transdermal drug delivery. Curr Med Chem 7:593-608. (Pubitemid 30396419)
7. Vávrová K, Zbytovská J, Hrabálek A. 2005. Amphiphilic transdermal permeation enhancers: Structure-activity relationships. Curr Med Chem 12:2273-2291. (Pubitemid 41179712)
8. Walker R, Smith EW. 1996. The role of percutaneous penetration enhancers. Adv Drug Deliv Rev 18:295-301.
9. Thakur RA, Wang Y, Michniak B. 2006. Essential oils and terpenes. In: Smith EW, Maibach HI, editors. Percutaneous penetration enhancers, 2nd edition. Florida: CRC Press. pp 159-173.
10. Obata Y, Takayama K, Machida Y, Nagai T. 1991. Combined effect of cyclic monoterpenes and ethanol on percutaneous absorption of diclofenac sodium. Drug Des Discov 8:137-144.
11. Okabe H, Obata Y, Takayama K, Nagai T. 1990. Percutaneous absorption enhancing effect and skin irritation of monocyclic monoterpenes. Drug Des Deliv 6:229-238. (Pubitemid 20302006)
12. Williams AC, Barry BW. 1991. Terpenes and the lipid-protein-partitioning theory of skin penetration enhancement. Pharm Res 8:17-24.
13. Amnuaikit C, Ikeuchi I, Ogawara K, Higaki K, Kimura T. 2005. Skin permeation of propranolol from polymeric film containing terpene enhancers for transdermal use. Int J Pharm 289:167-178. (Pubitemid 40093551)
14. Narishetty STK, Panchagnula R. 2004. Transdermal delivery of zidovudine: Effect of terpenes and their mechanism of action. J Control Release 95:367-379. (Pubitemid 38340488)
15. Williams AC, Barry BW. 1991. The enhancement index concept applied to terpene penetration enhancers for human skin and model lipophilic (estradiol) and hydrophilic (5-fluorouracil) drugs. Int J Pharm 74:157-168.
16. Arellano A, Santoyo S, Martin C, Ygartua P. 1996. Enhancing effect of terpenes on the in vitro percutaneous absorption of diclofenac sodium. Int J Pharm 130:141-145. (Pubitemid 26129793)
17. Kararli TT, Kirchhoff CF, Penzotti SC. 1995. Enhancement of transdermal transport of azidothymidine (AZT) with novel terpene and terpene-like enhancers: In vivo-in vitro correlations. J Control Release 34:43-51.
18. Okabe H, Takayama K, Ogura A, Nagai T. 1989. Effect of limonenes and related compounds on the percutaneous absorption of indomethacin. Drug Des Deliv 4:313-321. (Pubitemid 19157296)
19. Chantasart D, Li SK, He N, Warner KS, Prakongpan S, Higuchi WI. 2004. Mechanistic studies of branched-chain alkanols as skin permeation enhancers. J Pharm Sci 93:762-779. (Pubitemid 38332308)
20. He N, Li SK, Suhonen TM, Warner KS, Higuchi WI. 2003. Mechanistic study of alkyl azacycloheptanones as skin permeation enhancers by permeation and partition experiments with hairless mouse skin. J Pharm Sci 92:297-310. (Pubitemid 36169303)
21. He N, Warner KS, Chantasart D, Shaker DS, Higuchi WI, Li SK. 2004. Mechanistic study of chemical skin permeation enhancers with different polar and lipophilic functional groups. J Pharm Sci 93:1415-1430. (Pubitemid 38725016)
22. Kim YH, Ghanem AH, Mahmoud H, Higuchi WI. 1992. Short chain alkanols as transport enhancers for lipophilic and polar/ionic permeants in hairless mouse skin mechanism(s) of action. Int J Pharm 80:17-31.
23. Warner KS, Li SK, He N, Suhonen TM, Chantasart D, Bolikal D, Higuchi WI. 2003. Structureactivity relationship for chemical skin permeation enhancers: Probing the chemical microenvironment of the site of action. J Pharm Sci 92:1305-1322. (Pubitemid 36676475)
24. Yoneto K, Li SK, Higuchi WI, Shimabayashi S. 1998. Influence of the permeation enhancers 1-alkyl-2-pyrrolidones on permeant partitioning into the stratum corneum. J Pharm Sci 87:209-214. (Pubitemid 28081330)
25. Yoneto K, Ghanem AH, Higuchi WI, Peck KD, Li SK. 1995. Mechanistic studies of the 1-alkyl-2-pyrrolidones as skin permeation enhancers. J Pharm Sci 84:312-317.
26. He N, Warner KS, Higuchi WI, Li SK. 2005. Model analysis of flux enhancement across hairless mouse skin induced by chemical permeation enhancers. Int J Pharm 297:9-21. (Pubitemid 40720261)
27. Chantasart D, Sa-Nguandeekul P, Prakongpan S, Li SK, Higuchi WI. 2007. Comparison of the effects of chemical permeation enhancers on the lipoidal pathways of human epidermal membrane and hairless mouse skin and the mechanism of enhancer action. J Pharm Sci 96:2310-2326. (Pubitemid 47477889)
28. Lund W. 1994. Buffered solutions. In: Lund W, editor. The pharmaceutical codex, 12th edition. London: The Pharmaceutical Press. pp 66-68.
29. Klingman AM, Christophers E. 1963. Preparation of isolated sheets of human stratum corneum. Arch Dermatol 88:702-705.
30. Bronaugh RL, Collier SW. 1993. In vitro methods for measuring skin permeation. In: Zatz JL, editor. Skin permeation fundamentals and application. Wheaton, IL: Allured Publishing Corp. pp 93-111.
31. Kasting GB, Bowman LA. 1990. DC electrical properties of frozen, excised human skin. Pharm Res 7:134-143. (Pubitemid 20208064)
32. Peck KD, Ghanem AH, Higuchi WI. 1995. The effect of temperature upon the permeation of polar and ionic solutes through human epidermal membrane. J Pharm Sci 84:975-982.
33. Warner KS, Li SK, Higuchi WI. 2001. Influences of alkyl group chain length and polar head group on chemical skin permeation enhancement. J Pharm Sci 90:1143-1153.
34. Ghanem AH, Mahmaud H, Higuchi WI, Rohr U, Borsadia S, Lui P, Fox JL, Good WR. 1987. The effects of ethanol on the transport of b-estradiol and other permeants in hairless mouse skin. II. A new quantitative approach. J Control Release 6:75-83. (Pubitemid 18017723)
35. Raykar PV, Fung MC, Anderson BD. 1988. The role of protein and lipid domains in the uptake of solutes by human stratum corneum. Pharm Res 5:140-150.
36. Li SK, Ghanem AH, Peck KD, Higuchi WI. 1998. Characterization of the transport pathways induced during low to moderate voltage iontophoresis in human epidermal membrane. J Pharm Sci 87:40-48.
37. Li SK, Ghanem AH, Peck KD, Higuchi WI. 1999. Pore induction in human epidermal membrane during low to moderate voltage iontophoresis: A study using AC iontophoresis. J Pharm Sci 88:419-427.
38. Interactive LogKow (KowWin) Demo http://www. syrres.com/esc/est-kowdemo. htm (accessed March, 2008).
39. Ghafourian T, Zandasrar P, Hamishekar H, Nokhodchi A. 2004. The effect of penetration enhancers on drug delivery through skin: A QSAR study. J Control Release 99:113-125. (Pubitemid 39165738)
40. Hori M, Satoh S, Maibach HI, Guy RH. 1991. Enhancement of propranolol hydrochloride and diazepam skin absorption in vitro: Effect of enhancer lipophilicity. J Pharm Sci 80:32-35.
41. EL-Kattan A, Asbill C, Michniak B. 2000. The effect of terpene enhancer lipophilicity on the percutaneous permeation of hydrocortisone formulated in HPMC gel systems. Int J Pharm 198:179-189. (Pubitemid 30184855)
42. Jain AK, Thomas NS, Panchagnula R. 2002. Transdermal drug delivery of imipramine hydrochloride. I. Effect of terpenes. J Control Release 79:93-101. (Pubitemid 34168193)
43. Zhao K, Singh J. 1998. Mechanisms of percutaneous absorption of tamoxifen by terpenes: Eugenol, D-limonene and menthone. J Control Release 55:253-260. (Pubitemid 28477616)
44. Stott PW, Williams AC, Barry BW. 1998. Transdermal delivery from eutectic systems: Enhanced permeation of a model drug, ibuprofen. J Control Release 50:297-308.
45. Yamane MA, Williams AC, Barry BW. 1995. Terpene penetration enhancers in propylene glycol/ water co-solvent systems: Effectiveness and mechanism of action. J Pharm Pharmacol 47:978-989.
46. Li SK, Higuchi WI. 2006. Quantitative structureenhancement relationship and the microenvironment of the enhancer site of action. In Smith EW, Maibach HI, editors. Percutaneous penetration enhancers, 2nd edition. Boca Raton, FL: CRC Press. pp 35-49.
47. Li SK, Higuchi WI. 2006. Mechanistic studies of permeation enhancers. In Smith EW, Maibach HI, editors. Percutaneous penetration enhancers. 2nd edition. Boca Raton, FL: CRC Press. pp 271-292.
48. Kobayashi D, Matsuzawa T, Sugibayashi K, Morimoto Y, Kimura M. 1994. Analysis of the combined effect of 1-menthol and ethanol as skin permeation enhancers based on a two-layer skin model. Pharm Res 11:96-103. (Pubitemid 24040770)
49. Mackay KM, Williams AC, Barry BW. 2001. Effect of melting point of chiral terpenes on human stratum corneum uptake. Int J Pharm 228:89-97.
50. Moghimi HR, Williams AC, Barry BW. 1998. Enhancement by terpenes of 5-fluorouracil permeation through the stratum corneum: Model solvent approach. J Pharm Pharmacol 50:955-964.